A Study of Dotinurad Versus Allopurinol in Participants With Gout
for Gout
Drug: Dotinurad
Sites in Decatur +75 more locations
Sponsor: Crystalys Therapeutics
Sex: All·Age: 18 - 75
Code: NCT07089875·Phase 3·Recruiting·Listed Jul 2025
Paid Clinical Trials in Georgia
Georgia has 2,101 paid clinical trials enrolling now across cities including Atlanta, Decatur and Augusta. Search by condition, age, or phase to find compensated research studies accepting participants near you.
Research sites in Georgia include Emory University Hospital and Winship Cancer Institute, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
1,896 clinical trials
Get a weekly email when new trials open in Atlanta, GA.
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
for Tophaceous Gout
Drug: Dotinurad
Sites in Decatur +81 more locations
Sponsor: Crystalys Therapeutics
Sex: All·Age: 18 - 75
Code: NCT07089888·Phase 3·Recruiting·Listed Jul 2025
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
for Metabolic Dysfunction Associated Steatohepatitis (MASH)
Drug: Survodutide
Sites in Macon, Riverdale +161 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT06632444·Phase 3·Recruiting·Listed Oct 2024
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for Triple Negative Breast Cancer
Sites in Atlanta, Marietta +119 more locations
Sponsor: Gilead Sciences
Sex: All·Age: 18+
Code: NCT05633654·Phase 3·Recruiting·Listed Dec 2022
A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia
for Dystonia
Sites in Atlanta +36 more locations
Sponsor: Vima Therapeutics
Sex: All·Age: 18 - 65
Code: NCT07304089·Phase 2·Recruiting·Listed Dec 2025
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
for Metastatic Castration Sensitive Prostate Cancer (mCSPC)
Drug: Mevrometostat
Sites in Dalton, Ringgold +122 more locations
Sponsor: Pfizer
Sex: Male·Age: 18+
Code: NCT07028853·Phase 3·Recruiting·Listed Jun 2025
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
for Obesity
Drug: Eloralintide
Sites in Atlanta, Lawrenceville +24 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT07215559·Phase 2·Recruiting·Listed Oct 2025
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
for Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Drug: Coramitug
Sites in Gainesville +60 more locations
Sponsor: Novo Nordisk A/S
Sex: All·Age: 18+
Code: NCT07207811·Phase 3·Recruiting·Listed Oct 2025
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
for Melanoma
Sites in Athens +90 more locations
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 18+
Code: NCT06246916·Phase 3·Recruiting·Listed Feb 2024
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
for Proteinuric Kidney Disease
Sites in Atlanta, Decatur +137 more locations
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All·Age: 10 - 65
Code: NCT05312879·Phase 2, Phase 3·Recruiting·Listed Apr 2022
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
for Metabolic Dysfunction Associated Steatohepatitis
Drug: Survodutide
Sites in Atlanta, Macon +124 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT06632457·Phase 3·Recruiting·Listed Oct 2024
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
for Breast Cancer
Sites in Atlanta, Athens +170 more locations
Sponsor: Stemline Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06492616·Phase 3·Recruiting·Listed Jul 2024
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
for Carcinoma, Non-Small-Cell Lung
Drug: Amivantamab
Sites in Atlanta, Newnan +123 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT06667076·Phase 2·Recruiting·Listed Oct 2024
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
for Endometrial Cancer
Sites in Atlanta, Decatur +66 more locations
Sponsor: Genmab
Sex: Female·Age: 18+
Code: NCT07166094·Phase 3·Recruiting·Listed Sep 2025
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
for Crohn Disease
Sites in Atlanta, Macon +51 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07196722·Phase 2, Phase 3·Recruiting·Listed Sep 2025
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
for Colitis, Ulcerative
Sites in Atlanta, Macon +48 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 12+
Code: NCT07196748·Phase 3·Recruiting·Listed Sep 2025
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
for Cervical Cancer
Sites in Atlanta, Augusta +127 more locations
Sponsor: Pfizer
Sex: Female·Age: 18+
Code: NCT06952660·Phase 4·Recruiting·Listed May 2025
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
for Non-small Cell Lung Cancer
Drug: Zongertinib
Sites in Atlanta, Marietta +25 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT07195695·Phase 3·Recruiting·Listed Sep 2025
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
for Pediatric Migraine
Sites in Decatur, Brunswick +76 more locations
Sponsor: Pfizer
Sex: All·Age: 6 - 17
Code: NCT04649242·Phase 3·Recruiting·Listed Dec 2020
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
for Ovarian Cancer
Drug: INCB123667
Sites in Atlanta, Augusta +46 more locations
Sponsor: Incyte Corporation
Sex: Female·Age: 18+
Code: NCT07214779·Phase 3·Recruiting·Listed Oct 2025
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
for Bipolar Disorder
Sites in Atlanta, Decatur +31 more locations
Sponsor: Xenon Pharmaceuticals Inc.
Sex: All·Age: 18 - 74
Code: NCT07172516·Phase 3·Recruiting·Listed Sep 2025
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
for Osteoarthritis
Drug: Orforglipron
Sites in Decatur, Woodstock +24 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07153471·Phase 3·Recruiting·Listed Sep 2025
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
for Age-related Macular Degeneration (AMD)
Drug: Cemdisiran
Sites in Augusta, Marietta +139 more locations
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 50 - 85
Code: NCT06541704·Phase 3·Recruiting·Listed Aug 2024
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
for Geographic Atrophy Secondary to Age-related Macular Degeneration
Drug: Pegcetacoplan
Sites in Augusta +77 more locations
Sponsor: Apellis Pharmaceuticals, Inc.
Sex: All·Age: 60+
Code: NCT07215390·Phase 2·Recruiting·Listed Oct 2025
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
for End Stage Kidney Disease
Drug: Clazakizumab
Sites in Columbus, Lawrenceville +146 more locations
Sponsor: CSL Behring
Sex: All·Age: 18+
Code: NCT05485961·Phase 2, Phase 3·Recruiting·Listed Aug 2022
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
for Colorectal Neoplasms
Drug: Amivantamab
Sites in Atlanta, Athens +66 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT06750094·Phase 3·Recruiting·Listed Dec 2024
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
for Alzheimers Disease
Drug: Trontinemab
Sites in Decatur, Gainesville +31 more locations
Sponsor: Hoffmann-La Roche
Sex: All·Age: 50 - 90
Code: NCT07170150·Phase 3·Recruiting·Listed Sep 2025
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
for Plaque Psoriasis
Drug: Deucravacitinib
Sites in Savannah, Alpharetta +95 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 40+
Code: NCT07116967·Phase 3·Recruiting·Listed Aug 2025
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
for Migraine
Drug: Ubrogepant
Sites in Atlanta, Savannah +85 more locations
Sponsor: AbbVie
Sex: All·Age: 6 - 17
Code: NCT05125302·Phase 3·Recruiting·Listed Nov 2021
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for Carcinoma, Non-Small-Cell Lung
Drug: LY3537982
Sites in Atlanta, Athens +89 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06890598·Phase 3·Recruiting·Listed Mar 2025
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
for Breast Neoplasms
Sites in Newnan +62 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06966700·Phase 3·Recruiting·Listed May 2025
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
for Early Breast Cancer
Drug: Ribociclib
Sites in Savannah +77 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18 - 100
Code: NCT05827081·Phase 3·Recruiting·Listed Apr 2023
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
for Colorectal Neoplasms
Sites in Atlanta +107 more locations
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All·Age: 18+
Code: NCT05253651·Phase 3·Recruiting·Listed Feb 2022
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
for Chronic Obstructive Pulmonary Disease
Drug: Lunsekimig
Sites in Fayetteville, Cordele +64 more locations
Sponsor: Sanofi
Sex: All·Age: 40 - 80
Code: NCT07190209·Phase 3·Recruiting·Listed Sep 2025
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
for Alzheimers Disease
Drug: Trontinemab
Sites in Decatur, Columbus +33 more locations
Sponsor: Hoffmann-La Roche
Sex: All·Age: 50 - 90
Code: NCT07169578·Phase 3·Recruiting·Listed Sep 2025
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
for Carcinoma, Non-Small-Cell Lung
Drug: LY3537982
Sites in Atlanta, Athens +86 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06119581·Phase 3·Recruiting·Listed Nov 2023
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
for Heart Failure
Drug: Empagliflozin
Sites in Atlanta, Johns Creek +84 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT06935370·Phase 3·Recruiting·Listed Apr 2025
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
for Acne
Sites in Decatur +78 more locations
Sponsor: Sanofi Pasteur, a Sanofi Company
Sex: All·Age: 18 - 45
Code: NCT06316297·Phase 1, Phase 2·Recruiting·Listed Mar 2024
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
for Colorectal Neoplasms
Drug: Amivantamab
Sites in Atlanta +80 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT06662786·Phase 3·Recruiting·Listed Oct 2024
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
for Crohn's Disease
Drug: Tulisokibart
Sites in Atlanta, Macon +69 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 16 - 80
Code: NCT06430801·Phase 3·Recruiting·Listed May 2024